Skip to content

Clinical trials

Completed Cardiovascular Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Completed Country / region: Australia Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20033
20042
20062
20071
20084
20095
20106
20117
20126
20133
20146
20152
20162
20172
20188
20193
20203
20212
20223
20232
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
GlaxoSmithKline4
Kirby Institute4
Neuroscience Trials Australia4
The George Institute4
Abbott Medical Devices3
Amgen3
Boston Scientific Corporation3
Eli Lilly and Company3
The University of Western Australia3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases81
Heart Diseases15
Vascular Diseases13
Stroke11
Atherosclerosis7
Coronary Disease7
Dyslipidemias7
Heart Failure7
Hypertension7
Myocardial Infarction7

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.